Steven R. King serves as Executive at Jaguar Health, Inc., where they oversee executive responsibilities. Since joining the company, Steven R. King has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 17, 2024 involved exercising options for 612 shares valued at $0.
Steven R. King currently holds 1,756 shares of Jaguar Health, Inc. (JAGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven R. King has been a net neutral trader of JAGX stock. They have purchased $0 and sold $0 worth of shares.
Steven R. King's most recent insider trade was on May 17, 2024, when they sold 612 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 178 |
| $N/A |
| Discretionary |
| Aug 14, 2023 | JAGX | $0 | Award | 159,168 | $N/A | Discretionary |
| May 17, 2023 | JAGX | $0 | Option Exercise | 611 | $N/A | Discretionary |
| Apr 5, 2023 | JAGX | $0 | Option Exercise | 177 | $N/A | Discretionary |
| Apr 5, 2022 | JAGX | $0 | Option Exercise | 13,333 | $N/A | Discretionary |